BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2667 related articles for article (PubMed ID: 8035987)

  • 1. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
    Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
    Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal findings in melanoma-associated retinopathy.
    Borkowski LM; Grover S; Fishman GA; Jampol LM
    Am J Ophthalmol; 2001 Aug; 132(2):273-5. PubMed ID: 11476700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
    Keltner JL; Thirkill CE; Yip PT
    J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
    Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
    Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma.
    Jacobson DM; Adamus G
    Am J Ophthalmol; 2001 Jun; 131(6):806-8. PubMed ID: 11384586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma-associated paraneoplastic retinopathy: histopathologic observations.
    Gittinger JW; Smith TW
    Am J Ophthalmol; 1999 May; 127(5):612-4. PubMed ID: 10334362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
    Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
    Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
    Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
    Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
    Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
    Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome.
    Rizzo JF; Gittinger JW
    Ophthalmology; 1992 Aug; 99(8):1286-95. PubMed ID: 1325045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-associated retinopathy: does autoimmunity prolong survival?
    Chan C; O'Day J
    Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
    Milam AH; Saari JC; Jacobson SG; Lubinski WP; Feun LG; Alexander KR
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):91-100. PubMed ID: 8425845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
    Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
    Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Node way out.
    Vaphiades MS; Brown H; Whitcup SM
    Surv Ophthalmol; 2000; 45(1):77-83. PubMed ID: 10946083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
    Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
    PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
    Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
    Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 134.